Protocol Summaries: GSK1004723
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| 110159 | Phase 2 | A randomised, double-blind, placebo-controlled, 3-period crossover study to assess the efficacy and safety of single dose intranasal GSK1004723 compared with placebo in an allergen challenge chamber in male subjects with seasonal allergic rhinitis | Completed |
| HHI110157 | Phase 1 | See Detailed Description | Completed |